Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Avenir Wellness Solutions Inc.

Consumer Defensive US AVRW

0.0002USD
0.00(0%)

Last update at 2026-06-19T20:00:00Z

Day Range

0.00020.0002
LowHigh

52 Week Range

0.00010.04
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap0.02M
  • Volume242452
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.98000M
  • Revenue TTM2.04M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 1.44M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -3.44100M -18.49800M -13.19300M -30.62100M -21.37300M
Minority interest - - - 0.00000M 0.01000M
Net income -3.44400M -25.50900M -13.19300M -30.62100M -21.36300M
Selling general administrative 6.25M 10.17M 18.88M 11.37M 10.12M
Selling and marketing expenses 2.81M - - - -
Gross profit 3.11M 3.34M 4.38M 0.97M 0.39M
Reconciled depreciation 0.18M 1.58M 3.61M 0.94M 0.58M
Ebit -3.38400M - -16.86700M -13.17900M -11.73500M
Ebitda -3.20100M -16.45500M -9.03200M -27.21000M -16.68300M
Depreciation and amortization 0.18M - - - -
Non operating income net other - - - - -
Operating income -5.50600M -8.38600M -16.86700M -13.17900M -12.03500M
Other operating expenses 9.85M - - - -
Interest expense 0.06M 0.47M 0.55M 2.47M 4.11M
Tax provision 0.00300M 0.04M 0.00000M 0.00000M 0.00000M
Interest income 0.05M 0.05M 0.06M 0.04M 0.06M
Net interest income -0.00500M -0.41400M -0.49200M -2.43500M -4.05400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00300M - - - -
Total revenue 4.35M 4.90M 6.55M 2.05M 0.62M
Total operating expenses 8.62M 13.28M 23.42M 15.23M 12.66M
Cost of revenue 1.24M 1.56M 2.17M 1.08M 0.23M
Total other income expense net 2.06M -9.69800M 4.17M -15.00700M -5.28400M
Discontinued operations - - - - -
Net income from continuing ops -3.44400M -18.54000M -13.19300M -30.62100M -21.37300M
Net income applicable to common shares - - -13.19300M -30.62100M -21.36300M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2.61M 6.85M 40.57M 46.36M 32.46M
Intangible assets 0.30M 0.32M 22.29M 25.61M 16.10M
Earning assets - - - - -
Other current assets 0.29M 0.03M 0.12M 0.78M 1.14M
Total liab 12.49M 13.96M 24.46M 25.08M 18.95M
Total stockholder equity -9.88600M -7.10500M 16.11M 21.28M 13.51M
Deferred long term liab - - - - -
Other current liab 1.01M 0.86M 4.39M 2.03M 9.62M
Common stock 0.08M - 0.07M 0.06M 0.04M
Capital stock 0.08M 0.07M 0.07M 0.06M 0.04M
Retained earnings -123.39900M -119.95500M -94.44600M -81.25300M -50.63200M
Other liab - - - 3.29M 7.07M
Good will - 0.00000M 13.87M 13.87M 9.18M
Other assets - - 0.28M 0.06M 0.04M
Cash 0.05M 2.94M 0.02M 1.73M 4.10M
Cash and equivalents - - - - -
Total current liabilities 12.49M 13.91M 24.26M 14.47M 11.84M
Current deferred revenue 0.42M - - - -
Net debt 8.23M 6.95M 13.58M 14.18M -
Short term debt 8.28M - - - -
Short long term debt 8.24M 9.89M 13.59M 8.89M 0.73M
Short long term debt total 8.28M - - - -
Other stockholder equity 113.44M - 0.34M 0.67M 1.07M
Property plant equipment - - 2.14M 2.47M 0.70M
Total current assets 1.96M 5.93M 1.78M 3.85M 6.19M
Long term investments 0.26M 0.41M 0.22M 0.51M 0.26M
Net tangible assets - - -20.04400M -18.19400M -11.76700M
Short term investments - - - - -
Net receivables 1.42M 0.23M 0.36M 0.22M 0.14M
Long term debt - - - 7.01M -
Inventory 0.20M 0.14M 0.96M 0.66M 0.16M
Accounts payable 2.45M 1.06M 2.85M 2.13M 1.26M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.04M 0.04M 0.08M 0.06M 0.04M
Deferred long term asset charges - - - - -
Non current assets total 0.65M 0.93M 38.79M 42.51M 26.27M
Capital lease obligations 0.04M 0.17M 0.32M 0.42M 0.06M
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments 0.97M 13.84M -0.05700M -0.25000M -0.25900M
Change to liabilities - - 0.26M -0.93200M 0.30M
Total cashflows from investing activities 0.97M - -0.17500M -1.48800M -0.91700M
Net borrowings -0.02200M - 2.78M 6.06M 1.57M
Total cash from financing activities -0.02200M -0.83700M 2.78M 8.84M 12.61M
Change to operating activities - - 3.63M 0.73M -1.82400M
Net income -3.44400M -25.50900M -13.19300M -30.62100M -21.36300M
Change in cash -2.89400M 2.93M -1.70900M -2.37100M 3.60M
Begin period cash flow 2.94M 0.02M 1.73M 4.10M 0.50M
End period cash flow 0.05M 2.94M 0.02M 1.73M 4.10M
Total cash from operating activities -3.84300M -10.07300M -4.31500M -9.72200M -8.10200M
Issuance of capital stock - - - 0.00000M 2.50M
Depreciation 0.18M 1.58M 3.61M 0.92M 0.58M
Other cashflows from investing activities 0.97M - - -0.55000M -0.20000M
Dividends paid - - - - -
Change to inventory 0.02M 0.31M -0.23900M -0.14700M -0.11900M
Change to account receivables -0.21100M 0.16M -0.17400M -0.05900M -0.03200M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.16300M - - - -
Change to netincome - - 1.79M 18.89M 13.10M
Capital expenditures 0.05M 0.00100M 0.04M 0.67M 0.41M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.28M 1.72M 3.48M -0.42700M -1.67100M
Stock based compensation 0.62M 1.63M 3.88M 3.42M 4.14M
Other non cash items -2.48300M -0.70500M -1.38200M 16.60M 6.88M
Free cash flow -3.89700M -10.07400M -4.43300M -10.41000M -8.56000M

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AVRW
Avenir Wellness Solutions Inc.		 - -% 0.0002 - - 0.0081 - 4.34 -1.2154
NSRGF
Nestle SA		 - -% 98.98 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR		 -0.78 0.80% 97.32 26.82 18.66 3.18 7.07 3.81 21.70
GPDNF
Danone S.A		 - -% 74.80 25.33 17.39 1.97 2.55 1.88 11.70
DANOY
Danone PK		 0.22 1.46% 15.29 24.23 17.64 1.88 2.57 1.88 11.70

Reports Covered

Stock Research & News

View All

Profile

Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as well as online and in-store at national drug, mass retailers, grocery chains, convenience stores, and on Amazon.com. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in January 2023. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is based in Sherman Oaks, California.

Avenir Wellness Solutions Inc.

15233 Ventura Boulevard, Sherman Oaks, CA, United States, 91403

Key Executives

Name Title Year Born
Mr. Robert Davidson Founder, Chief Scientist & Chairman of the Board 1967
Ms. Nancy Duitch CEO & Director 1955
Mr. Joel M. Bennett CPA CFO, Chief Accounting Officer, Secretary & Treasurer 1962
Ms. Patricia Hess Chief Operating Officer NA
Mr. Bhaumik Patel Director of New Technologies NA
Mr. John Cammarano Jr. Senior Vice President of Sales 1964
Dr. Rahul Dixit M.D. Chief Medical Officer & Member of Medical Advisory Board NA
Mr. Rick Petry Senior VP & Executive Creative Director NA
Mr. Joel M. Bennett CPA CFO, Chief Accounting Officer, Secretary, Treasurer & Interim CEO 1962

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions